NCT04999384 2025-11-18First in Human, Dose Escalation Study of AN4005Adlai Nortye Biopharma Co., Ltd.Phase 1 Recruiting31 enrolled
NCT05279300 2025-08-11A Study of CS5001 in Patients With Advanced Solid Tumors and LymphomasCStone PharmaceuticalsPhase 1 Recruiting480 enrolled